Italian researchers reporting in the journal Cancers found a 32% increase in the odds for cancer in the first year after a ...

Roche’s Genentech is backing this year’s Walk to End Lupus Now, taking up a sponsorship opportunity claimed by GSK in ...

Biogen’s lupus drug candidate litifilimab has improved outcomes in another phase 2 trial, adding to the momentum behind a program barreling toward pivotal data in two forms of t ...

Biogen announced positive results from the Phase 2 part of the AMETHYST Phase 2/3 study (part A) of investigational therapy, ...

Leading rheumatology research organizations unite to support the research workforce and fuel lupus breakthroughs. ATLANTA, April 2, 2026 /PRNewswire/ -- Today, the Lupus Research Alliance (LRA), in ...

Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The SLE clinical trial analysis report delivers ...

With enpatoran soon entering Phase III clinical trials, the Phase II safety and efficacy results support the drug’s development.

Data are beginning to provide a clearer picture of chimeric antigen receptor T-cell therapy’s benefits and risks in lupus, ...

William Blair hailed a positive readout in cutaneous lupus erythematosus as a turning point for Biogen, while RBC Capital analysts called the results “another derisking step” for the company’s ...

We are joined by experts who share what you need to know to protect your kidneys, including the importance of early detection ...

Selena Gomez’s case raises real questions about lupus, transplants, and whether a safe pregnancy is possible.